首页> 外文OA文献 >High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agents
【2h】

High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agents

机译:高松弛度g修饰的高密度脂蛋白作为磁共振成像造影剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

There is an ongoing desire to produce high-relaxivity, Gd-based magnetic resonance imaging (MRI) contrast agents. These may allow for lower doses to be used, which is especially important in view of the current safety concerns surrounding Gd in patients. Here we report the synthesis of a high-relaxivity MRI contrast agent, by incorporating Gd-chelating lipids that coordinate two water molecules into high-density lipoprotein (q = 2 HDL). We compared the properties of q = 2 HDL with those of an analogous HDL particle labeled with Gd-chelating lipids that coordinate only one water molecule (q = 1 HDL). We found that the q = 2 HDL possessed an elevated r(1) of 41 mM(-1) s(-1) compared to 9 mM(-1) s(-1) for q = 1 HDL at 20 MHz, but the q = 2 HDL exhibited high R(2)* values at high fields, precluding imaging above 128 MHz. While carrying out this investigation we observed that enlarged, disrupted particles were formed when the synthesis was carried out above the lipid critical micelle concentration (cmc), indicating the importance of synthesis below the cmc when modifying lipoproteins in this manner. The high relaxivity of q = 2 HDL means it will be an efficacious contrast agent for future MR imaging studies
机译:一直需要生产高松弛率的基于Gd的磁共振成像(MRI)造影剂。这些可能允许使用较低的剂量,鉴于当前围绕患者Gd的安全性考虑,这一点尤其重要。在这里,我们通过结合Gd螯合脂质(可将两个水分子协调成高密度脂蛋白(q = 2 HDL))来报告高松弛度MRI造影剂的合成。我们比较了q = 2 HDL的特性与标记有Gd螯合脂质的类似HDL颗粒的特性,这些脂质仅与一个水分子配位(q = 1 HDL)。我们发现q = 2 HDL在20 MHz时q = 1 HDL具有9 mM(-1)s(-1)的r(1)提高到41 mM(-1)s(-1)。 q = 2 HDL在高场显示高R(2)*值,从而排除了128 MHz以上的成像。在进行这项研究时,我们观察到当合成在脂质临界胶束浓度(cmc)以上进行时,会形成扩大的破坏颗粒,这表明以这种方式修饰脂蛋白时在cmc以下合成的重要性。 q = 2 HDL的高弛豫性意味着它将成为未来MR成像研究的有效造影剂

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号